CERAXON®, (Citicoline, Cognizin, NeurAxon, Somazina, Synapsine) 5 ampoules/pack, 1000 mg(4ml)/ampoule
CERAXON (Citicoline, Cognizin, NeurAxon, Somazina, Synapsine) is a nootropic supplement or cognitive enhancer for treating cerebrovascular disorders, head injury and Parkinson's disease. The active substance of Ceraxon is Citicoline that restores damaged cell membranes, inhibits the action of phospholipases by preventing excessive formation of free radicals, and prevents cell death by affecting the mechanisms of apoptosis. Ceraxon is effective in treating damaged tissue after stroke, traumatic brain injury and its consequences, disorders caused by cerebral pathology of degenerative origin.
- Reduce Ischemic Stroke (Acute Phase).
- Recover After Ischemic and Hemorrhagic Stroke.
- Treat Traumatic Brain Injury (Acute and Recovery Period).
- Eradicate Cognitive Impairment in Degenerative and Vascular Diseases.
- Treat Parkinson's Disease.
- Remove Acute Pancreatitis.
GUARANTEE & EXPIRY DATE
100% Original from the Italian Ferrer Internacional, S.A.
All packs are air tight sealed and expire up to 07.2022.
Ceraxon includes the active substance Citicoline, a precursor of key ultrastructural components of the cell membrane (mainly phospholipids). It has a vast spectrum of action: improves cholinergic transmission and reduces the amount of damaged tissue after acute phase of stroke; reduces the duration of post-traumatic coma and the severity of neurological symptoms after traumatic brain injury; stimulates the formation of new phospholipids thus improving the function of ion-exchange membrane pumps nerve cells; stabilizes the membrane of neurons. As a consequence, Ceraxon is highly effective in treating the symptoms of hypoxia, complications and consequences of cerebral blood flow, acute phase of cerebrovascular accidents, cerebral edema, and cognitive, sensory and motor neurological disorders. Further read: https://en.wikipedia.org/wiki/Citicoline
PACKAGING & DOSAGE
Active substance: citicoline sodium (equivalent to 500mg citicoline)
Excipients: 1M hydrochloric acid or 1M sodium hydroxide, рH 6,7-7,1, water for injections max-4ml
Ceraxon is administered by slow intravenous injection (duration 3-5 min) or by drip infusion (40-60 drops/min). The intravenous rout is preferred.
Acute phase of stroke and traumatic brain injury: recommended dose is 1000mg every 12 hours, duration - not less than 6 weeks.
Recovery therapy after ischemic and hemorrhagic strokes, traumatic brain injury, cognitive impairment of degenerative and vascular etiology:†recommended dose is 500-2000mg/day (5-10ml 1-2 times per day).
Parkinson's disease: recommended dose is 500mg 1 time per†day for 3-4 weeks.
The MHRA and FDA has not evaluated or endorsed this product. Please consult your physician prior to using this or any other nutritional supplements or medications.
Store in dry place at room temperature. Do not exceed storage temperature higher than 30 degrees Celcius. Keep away from direct sunlight. Keep locked and away from children.
Ask us any questions about Ceraxon.